{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:53:01Z","timestamp":1787169181900,"version":"build-2736575974"},"reference-count":165,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Bando Ricerca Salute 2018-Regione Toscana"},{"DOI":"10.13039\/501100003980","name":"Istituto Toscano Tumori","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003980","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Istituto per lo Studio, la Prevenzione e la Rete Oncologica"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Secretory Leukocyte Protease Inhibitor (SLPI) is a conserved serine protease inhibitor expressed on mucosal surfaces, which has multiple functions including anti-protease, anti-microbial and anti-inflammatory properties. SLPI plays critical roles in tissue homeostasis and pathology. Through its anti-protease ability, SLPI safeguards tissues from excessive damage caused by proteolytic enzymes released during inflammation and contributes to extracellular matrix remodeling, thereby influencing the cellular and tumor microenvironment. Furthermore, SLPI expression is implicated in shaping the immune landscape that facilitates tumor progression, and in driving epithelial\u2013mesenchymal transition (EMT). Consequently, it is not surprising that SLPI plays a complex and context-dependent role across various malignancies. It is overexpressed in most cancers such as colorectal, gastric, pancreatic, and breast carcinomas, and this overexpression often correlates with a more advanced and aggressive disease. Conversely, its levels are reduced in head and neck squamous cell carcinoma and hepatocellular carcinoma, where elevated expression may be associated with a more favorable prognosis. This diverse behavior underscores that SLPI function in cancer is tissue-specific and dependent on the functional or pathological state. In prostate cancer, SLPI expression exhibits a bimodal behavior: levels are reduced in the early stages of the disease compared to normal tissues but become significantly upregulated in more advanced and aggressive stages of disease, with significantly higher levels observed in patients with castration-resistant prostate cancer. Elevated SLPI levels in prostate cancer correlate with a reduced prostate-specific antigen (PSA) progression-free survival. In this review, we outline the current evidence regarding the multifaceted functions of SLPI and its expanding role in cancer, focusing primarily on the recently described molecular mechanisms and clinical significance of SLPI in prostate carcinoma.<\/jats:p>","DOI":"10.3390\/cancers18030487","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:38:12Z","timestamp":1770046692000},"page":"487","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SLPI in Prostate Cancer"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1408-4504","authenticated-orcid":false,"given":"Dario","family":"Rosini","sequence":"first","affiliation":[{"name":"Laboratory of Cancer Genetics, Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), 50139 Florence, Italy"},{"name":"Doctorate School GENETICS, ONCOLOGY and CLINICAL MEDICINE (GenOMeC), University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cosi","sequence":"additional","affiliation":[{"name":"Laboratory of Cancer Genetics, Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), 50139 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"De Iaco","sequence":"additional","affiliation":[{"name":"Laboratory of Cancer Genetics, Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), 50139 Florence, Italy"},{"name":"Doctorate School GENETICS, ONCOLOGY and CLINICAL MEDICINE (GenOMeC), University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4073-8339","authenticated-orcid":false,"given":"Arcangelo","family":"Sebastianelli","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence, 50139 Florence, Italy"},{"name":"Unit of Urological Minimally Invasive, Robotic Surgery and Kidney Transplantation, Careggi Hospital, University of Florence, 50139 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4685-4437","authenticated-orcid":false,"given":"Gioia","family":"Di Stefano","sequence":"additional","affiliation":[{"name":"Histopathology and Molecular Diagnostic, Careggi University Hospital, 50139 Florence, Italy"},{"name":"Department of Surgery and Translational Medicine, University of Florence, 50139 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8699-985X","authenticated-orcid":false,"given":"Sergio","family":"Serni","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence, 50139 Florence, Italy"},{"name":"Unit of Urological Minimally Invasive, Robotic Surgery and Kidney Transplantation, Careggi Hospital, University of Florence, 50139 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2614-944X","authenticated-orcid":false,"given":"Gabriella","family":"Nesi","sequence":"additional","affiliation":[{"name":"Histopathology and Molecular Diagnostic, Careggi University Hospital, 50139 Florence, Italy"},{"name":"Department of Surgery and Translational Medicine, University of Florence, 50139 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9087-9404","authenticated-orcid":false,"given":"Rosario","family":"Notaro","sequence":"additional","affiliation":[{"name":"Laboratory of Cancer Genetics, Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), 50139 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2686-6457","authenticated-orcid":false,"given":"Maria","family":"De Angioletti","sequence":"additional","affiliation":[{"name":"Laboratory of Cancer Genetics, Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), 50139 Florence, Italy"},{"name":"Istituto di Chimica dei Composti Organometallici (ICCOM)\u2014National Council of Research, Sesto Fiorentino, 50019 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e077738","DOI":"10.1136\/bmj-2023-077738","article-title":"Prostate cancer incidence and mortality in Europe and implications for screening activities: Population based study","volume":"386","author":"Vaccarella","year":"2024","journal-title":"BMJ"},{"key":"ref_2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The Lancet Commission on prostate cancer: Planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"key":"ref_4","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2015.17703","article-title":"Familial Risk and Heritability of Cancer Among Twins in Nordic Countries","volume":"315","author":"Mucci","year":"2016","journal-title":"Jama"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1046\/j.1464-410X.2003.04232.x","article-title":"A systematic review and meta-analysis of familial prostate cancer risk","volume":"91","author":"Johns","year":"2003","journal-title":"BJU Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/jamaoncol.2019.0826","article-title":"Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality","volume":"5","author":"Dess","year":"2019","journal-title":"JAMA Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41588-020-00748-0","article-title":"Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction","volume":"53","author":"Conti","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrurol.2016.89","article-title":"The role of the prostate in male fertility, health and disease","volume":"13","author":"Verze","year":"2016","journal-title":"Nat. Rev. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/ng1999","article-title":"Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24","volume":"39","author":"Gudmundsson","year":"2007","journal-title":"Nat. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrg2507","article-title":"Prostate cancer genomics: Towards a new understanding","volume":"10","author":"Witte","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41588-022-01168-y","article-title":"Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation","volume":"54","author":"Baca","year":"2022","journal-title":"Nat. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/s41588-023-01534-4","article-title":"Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants","volume":"55","author":"Wang","year":"2023","journal-title":"Nat. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa2407934","article-title":"Assessment of a Polygenic Risk Score in Screening for Prostate Cancer","volume":"392","author":"McHugh","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_16","first-page":"21","article-title":"Major dietary factors and prostate cancer risk: A prospective multicenter case-control study","volume":"63","author":"Salem","year":"2011","journal-title":"Nutr. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMe2300807","article-title":"Localized Prostate Cancer\u2014Then and Now","volume":"388","author":"Sartor","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMc2406108","article-title":"Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer","volume":"391","author":"Holmberg","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","article-title":"Prostate cancer","volume":"398","author":"Sandhu","year":"2021","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1200\/JCO-25-00007","article-title":"Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update","volume":"43","author":"Garje","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nature06024","article-title":"Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer","volume":"448","author":"Tomlins","year":"2007","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrc.2017.20","article-title":"The ETS family of oncogenic transcription factors in solid tumours","volume":"17","author":"Sizemore","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/978-3-030-32656-2_18","article-title":"Oncogenic ETS Factors in Prostate Cancer","volume":"1210","author":"Nicholas","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.canlet.2022.01.009","article-title":"ETS factors in prostate cancer","volume":"530","author":"Qian","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"Joyce","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41568-020-0267-9","article-title":"Prostate carcinogenesis: Inflammatory storms","volume":"20","author":"Guo","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrurol.2017.167","article-title":"The inflammatory microenvironment and microbiome in prostate cancer development","volume":"15","author":"Sfanos","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.biochi.2015.09.002","article-title":"The kallikrein-related peptidase family: Dysregulation and functions during cancer progression","volume":"122","author":"Kryza","year":"2016","journal-title":"Biochimie"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.steroids.2017.11.006","article-title":"Neutrophil elastase in the tumor microenvironment","volume":"133","author":"Lerman","year":"2018","journal-title":"Steroids"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41568-021-00436-z","article-title":"Remodelling of the tumour microenvironment by the kallikrein-related peptidases","volume":"22","author":"Srinivasan","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"107347","DOI":"10.1016\/j.jbc.2024.107347","article-title":"Extracellular proteolysis in cancer: Proteases, substrates, and mechanisms in tumor progression and metastasis","volume":"300","author":"Radisky","year":"2024","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cytogfr.2015.12.001","article-title":"Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response","volume":"28","author":"Majewski","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cytogfr.2021.01.005","article-title":"Secretory Leukocyte Protease Inhibitor (SLPI) in mucosal tissues: Protects against inflammation, but promotes cancer","volume":"59","author":"Nugteren","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1016\/S0021-9258(19)85783-6","article-title":"The toxin-agglutinin fold. A new group of small protein structures organized around a four-disulfide core","volume":"255","author":"Drenth","year":"1980","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"11509","DOI":"10.1016\/S0021-9258(19)68430-9","article-title":"Biochemical characterization of a novel whey protein from murine milk","volume":"256","author":"Piletz","year":"1981","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1515\/bchm2.1966.343.1.185","article-title":"On a hormone dependent inhibitor of proteolytic enzymes in male accessory sex glands and in sperm","volume":"343","author":"Haendle","year":"1965","journal-title":"Hoppe Seylers Z. Physiol. Chem."},{"key":"ref_41","first-page":"709","article-title":"Characterization of an acid-stable proteinase inhibitor in human cervical mucus","volume":"355","author":"Wallner","year":"1974","journal-title":"Hoppe Seylers Z. Physiol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/00016487809121451","article-title":"Quantitation of human granulocyte protease inhibitors in non-purulent bronchial lavage fluids","volume":"85","author":"Tegner","year":"1978","journal-title":"Acta Oto-Laryngol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1073\/pnas.83.18.6692","article-title":"Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase","volume":"83","author":"Thompson","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7883","DOI":"10.1093\/nar\/14.20.7883","article-title":"Isolation and sequence of a human gene encoding a potent inhibitor of leukocyte proteases","volume":"14","author":"Stetler","year":"1986","journal-title":"Nucleic Acids Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1432-1033.1986.tb09940.x","article-title":"Molecular cloning and expression of cDNA for human antileukoprotease from cervix uterus","volume":"160","author":"Heinzel","year":"1986","journal-title":"Eur. J. Biochem."},{"key":"ref_46","unstructured":"Taylor, J.C., and Mittman, C. (1986). Structure, genomic organization and tissue distribution of human secretory leukocyte-protease inhibitor (SLPI): A potent inhibitor of neutrophil elastase. Pulmonary Emphysema and Proteolysis, Academic Press."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj20020869","article-title":"A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein","volume":"368","author":"Clauss","year":"2002","journal-title":"Biochem. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1101\/gr.6004607","article-title":"Comparative sequence analyses reveal rapid and divergent evolutionary changes of the WFDC locus in the primate lineage","volume":"17","author":"Hurle","year":"2007","journal-title":"Genome Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0092-8674(00)81880-2","article-title":"Secretory leukocyte protease inhibitor: A macrophage product induced by and antagonistic to bacterial lipopolysaccharide","volume":"88","author":"Jin","year":"1997","journal-title":"Cell"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1006\/jmbi.1997.0983","article-title":"Solution structure of R-elafin, a specific inhibitor of elastase","volume":"268","author":"Francart","year":"1997","journal-title":"J. Mol. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1007\/s00018-003-3120-x","article-title":"Canonical protein inhibitors of serine proteases","volume":"60","author":"Krowarsch","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/j.1460-2075.1988.tb02819.x","article-title":"The 2.5 A X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine alpha-chymotrypsin","volume":"7","author":"Fendrich","year":"1988","journal-title":"EMBO J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1107\/S0909049507060670","article-title":"Complex of human neutrophil elastase with 1\/2SLPI","volume":"15","author":"Koizumi","year":"2008","journal-title":"J. Synchrotron Radiat."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"8148","DOI":"10.4049\/jimmunol.0901716","article-title":"Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation","volume":"183","author":"Weldon","year":"2009","journal-title":"J. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1107\/S090904951302133X","article-title":"Structure basis 1\/2SLPI and porcine pancreas trypsin interaction","volume":"20","author":"Fukushima","year":"2013","journal-title":"J. Synchrotron Radiat."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1016\/S0021-9258(19)39026-X","article-title":"Location of the protease-inhibitory region of secretory leukocyte protease inhibitor","volume":"265","author":"Eisenberg","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1128\/iai.64.11.4520-4524.1996","article-title":"Antibacterial activity of antileukoprotease","volume":"64","author":"Hiemstra","year":"1996","journal-title":"Infect. Immun."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1086\/514098","article-title":"Antileukoprotease: An endogenous protein in the innate mucosal defense against fungi","volume":"176","author":"Tomee","year":"1997","journal-title":"J. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1476-5381.1995.tb15892.x","article-title":"Pharmacological activity of the C-terminal and N-terminal domains of secretory leukoprotease inhibitor in vitro","volume":"115","author":"Masuda","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1172\/JCI117331","article-title":"Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester","volume":"94","author":"Maruyama","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jlb.61.6.695","article-title":"Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils","volume":"61","author":"Sallenave","year":"1997","journal-title":"J. Leukoc. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/j.1939-4640.1995.tb01733.x","article-title":"Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization","volume":"16","author":"Ohlsson","year":"1995","journal-title":"J. Androl."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/09629359990478","article-title":"Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cells","volume":"8","author":"Bergenfeldt","year":"1999","journal-title":"Mediat. Inflamm."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF01211182","article-title":"Localization of immunoreactive secretory leukocyte protease inhibitor (SLPI) in intestinal mucosa","volume":"31","author":"Bergenfeldt","year":"1996","journal-title":"J. Gastroenterol."},{"key":"ref_65","first-page":"L601","article-title":"Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells","volume":"268","author":"Simpson","year":"1995","journal-title":"Am. J. Physiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI118056","article-title":"Secretory leukocyte protease inhibitor: A human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro","volume":"96","author":"McNeely","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"21886","DOI":"10.1074\/jbc.271.36.21886","article-title":"Antileukoprotease inhibits stratum corneum chymotryptic enzyme. Evidence for a regulative function in desquamation","volume":"271","author":"Franzke","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/00003246-200005000-00003","article-title":"Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia","volume":"28","author":"Grobmyer","year":"2000","journal-title":"Crit. Care Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4049\/jimmunol.171.3.1507","article-title":"Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: Implications for resolution of the inflammatory response","volume":"171","author":"Odaka","year":"2003","journal-title":"J. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/mi.2016.72","article-title":"Dendritic cells from the human female reproductive tract rapidly capture and respond to HIV","volume":"10","author":"Shen","year":"2017","journal-title":"Mucosal Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.4049\/jimmunol.179.10.6588","article-title":"Secretory leukoprotease inhibitor in mucosal lymph node dendritic cells regulates the threshold for mucosal tolerance","volume":"179","author":"Samsom","year":"2007","journal-title":"J. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1182\/blood-2004-03-1179","article-title":"Interactions between the megakaryocyte\/platelet-specific beta1 tubulin and the secretory leukocyte protease inhibitor SLPI suggest a role for regulated proteolysis in platelet functions","volume":"104","author":"Schulze","year":"2004","journal-title":"Blood"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1124\/mol.64.4.833","article-title":"Up-regulation of secretory leukocyte protease inhibitor (SLPI) in the brain after ischemic stroke: Adenoviral expression of SLPI protects brain from ischemic injury","volume":"64","author":"Wang","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1164\/ajrccm\/147.3.710","article-title":"Distribution of secretory leukoprotease inhibitor in the human nasal airway","volume":"147","author":"Lee","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1042\/cs0690017","article-title":"Extracellular elastolytic activity in human lung lavage: A comparative study between smokers and non-smokers","volume":"69","author":"Smith","year":"1985","journal-title":"Clin. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/CS20050115","article-title":"SLPI and elafin: One glove, many fingers","volume":"110","author":"Williams","year":"2006","journal-title":"Clin. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"33648","DOI":"10.1074\/jbc.M203710200","article-title":"Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination","volume":"277","author":"Taggart","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1084\/jem.20050768","article-title":"Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding","volume":"202","author":"Taggart","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbamcr.2005.07.006","article-title":"Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function","volume":"1745","author":"Yang","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1172\/JCI119254","article-title":"Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases","volume":"99","author":"Zhang","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1182\/blood-2013-06-508887","article-title":"A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation","volume":"123","author":"Klimenkova","year":"2014","journal-title":"Blood"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1043-4666(02)00485-4","article-title":"Effects of secretory leukocyte protease inhibitor on the tumor necrosis factor-alpha production and NF-kappaB activation of lipopolysaccharide-stimulated macrophages","volume":"21","author":"Sano","year":"2003","journal-title":"Cytokine"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ygyno.2011.04.052","article-title":"Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells","volume":"122","author":"Hoskins","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/gutjnl-2013-306149","article-title":"Human buccal epithelium acquires microbial hyporesponsiveness at birth, a role for secretory leukocyte protease inhibitor","volume":"64","author":"Menckeberg","year":"2015","journal-title":"Gut"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2567.2011.03451.x","article-title":"Serine leucocyte proteinase inhibitor-treated monocyte inhibits human CD4(+) lymphocyte proliferation","volume":"133","author":"Guerrieri","year":"2011","journal-title":"Immunology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/ni1434","article-title":"Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI","volume":"8","author":"Xu","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/80489","article-title":"Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing","volume":"6","author":"Ashcroft","year":"2000","journal-title":"Nat. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0092-8674(02)01141-8","article-title":"Conversion of proepithelin to epithelins: Roles of SLPI and elastase in host defense and wound repair","volume":"111","author":"Zhu","year":"2002","journal-title":"Cell"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.4049\/jimmunol.170.11.5583","article-title":"Wound healing and expression of antimicrobial peptides\/polypeptides in human keratinocytes, a consequence of common growth factors","volume":"170","author":"Cowland","year":"2003","journal-title":"J. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1172\/JCI28422","article-title":"Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor","volume":"116","author":"Thapa","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.12968\/jowc.2022.31.Sup7.S15","article-title":"Levels of secretory leukocyte protease inhibitor expression in acute wounds","volume":"31","author":"Lai","year":"2022","journal-title":"J. Wound Care"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1086\/517272","article-title":"Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines","volume":"176","author":"Tomee","year":"1997","journal-title":"J. Infect. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1006\/bbrc.1998.9069","article-title":"Antileukoprotease in human skin: An antibiotic peptide constitutively produced by keratinocytes","volume":"248","author":"Wiedow","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0016-5085(00)70359-3","article-title":"Constitutive and regulated secretion of secretory leukocyte proteinase inhibitor by human intestinal epithelial cells","volume":"118","author":"Merlin","year":"2000","journal-title":"Gastroenterology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.2174\/1381612043383566","article-title":"Antimicrobial peptides: Mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics","volume":"10","author":"Hiemstra","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1111\/j.1601-0825.1997.tb00377.x","article-title":"Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I","volume":"3","author":"Wahl","year":"1997","journal-title":"Oral. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1164\/rccm.200804-615OC","article-title":"Secretory leukocyte protease inhibitor: A secreted pattern recognition receptor for mycobacteria","volume":"179","author":"Gomez","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Py, B., Basmaciogullari, S., Bouchet, J., Zarka, M., Moura, I.C., Benhamou, M., Monteiro, R.C., Hocini, H., Madrid, R., and Benichou, S. (2009). The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane. PLoS ONE, 4.","DOI":"10.1371\/annotation\/657cd713-aaac-4ebb-80ad-3ec8dfb12b42"},{"key":"ref_99","first-page":"185","article-title":"The level of secretory leukocyte protease inhibitor is decreased in metastatic head and neck squamous cell carcinoma","volume":"39","author":"Cordes","year":"2011","journal-title":"Int. J. Oncol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1016\/j.ajpath.2011.02.017","article-title":"Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma","volume":"178","author":"Wen","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/mc.23445","article-title":"FAP(high) \u03b1-SMA(low) cancer-associated fibroblast-derived SLPI protein encapsulated in extracellular vesicles promotes ovarian cancer development via activation of PI3K\/AKT and downstream signaling pathways","volume":"61","author":"Sun","year":"2022","journal-title":"Mol. Carcinog."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1158\/1055-9965.EPI-11-0593","article-title":"Integrated analysis of multiple gene expression profiling datasets revealed novel gene signatures and molecular markers in nasopharyngeal carcinoma","volume":"21","author":"Huang","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(06)70579-4","article-title":"Proteins with whey-acidic-protein motifs and cancer","volume":"7","author":"Bouchard","year":"2006","journal-title":"Lancet Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"154633","DOI":"10.1016\/j.prp.2023.154633","article-title":"Secretory leukocyte protease inhibitor (SLPI) in cancer pathophysiology: Mechanisms of action and clinical implications","volume":"248","author":"Zhang","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12935-025-03962-0","article-title":"Cellular and molecular features of acute myeloid leukemia investigation based on single-cell RNA sequencing","volume":"25","author":"Li","year":"2025","journal-title":"Cancer Cell Int."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"15550","DOI":"10.1038\/s41598-024-66400-7","article-title":"SLPI overexpression in hMSCs could be implicated in the HSC gene expression profile in AML","volume":"14","author":"Azevedo","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_107","first-page":"527","article-title":"Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells","volume":"28","author":"Choi","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"108292","DOI":"10.18632\/oncotarget.22660","article-title":"Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers","volume":"8","author":"Kozin","year":"2017","journal-title":"Oncotarget"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nature14403","article-title":"A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis","volume":"520","author":"Wagenblast","year":"2015","journal-title":"Nature"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.canlet.2019.12.018","article-title":"Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p\/SLPI-mediated vasculogenic mimicry formation","volume":"473","author":"Yang","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"167975","DOI":"10.1016\/j.bbadis.2025.167975","article-title":"ETV4 and ETV1-mediated downregulation of the secretory leukocyte protease inhibitor contributes to the indolent phenotype of early-stage prostate cancer","volume":"1871","author":"Cosi","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e16580","DOI":"10.1002\/advs.202516580","article-title":"SLPI+ AT2-Like Cells Orchestrate Lung Adenocarcinoma Invasion via Wnt Pathway Activation and Stromal Crosstalk in a Spatially Defined Margin Niche","volume":"13","author":"Wang","year":"2025","journal-title":"Adv. Sci (Weinh)"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/s43018-025-01039-5","article-title":"Spatiotemporal analyses of the pan-cancer single-cell landscape reveal widespread profibrotic ecotypes associated with tumor immunity","volume":"6","author":"Han","year":"2025","journal-title":"Nat. Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/carcin\/bgt382","article-title":"Secretory leukocyte protease inhibitor modulates urethane-induced lung carcinogenesis","volume":"35","author":"Treda","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12935-019-0942-7","article-title":"Secretory leukocyte protease inhibitor suppresses HPV E6-expressing HNSCC progression by mediating NF-\u03baB and Akt pathways","volume":"19","author":"Jin","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e9400","DOI":"10.7717\/peerj.9400","article-title":"Targeting secretory leukocyte protease inhibitor (SLPI) inhibits colorectal cancer cell growth, migration and invasion via downregulation of AKT","volume":"8","author":"Wei","year":"2020","journal-title":"PeerJ"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12672-022-00535-9","article-title":"Inhibition of secretory leukocyte protease inhibitor (SLPI) promotes the PUMA-mediated apoptosis and chemosensitivity to cisplatin in colorectal cancer cells","volume":"14","author":"Wei","year":"2023","journal-title":"Discov. Oncol."},{"key":"ref_118","first-page":"1495","article-title":"SLPI promotes the gastric cancer growth and metastasis by regulating the expression of P53, Bcl-2 and Caspase-8","volume":"21","author":"Du","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"29999","DOI":"10.1074\/jbc.M203503200","article-title":"Secretory leukocyte protease inhibitor mediates proliferation of human endometrial epithelial cells by positive and negative regulation of growth-associated genes","volume":"277","author":"Zhang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12094-014-1232-4","article-title":"Secretory leukocyte protease inhibitor is a proliferation and survival factor for pancreatic cancer cells","volume":"17","author":"Zuo","year":"2015","journal-title":"Clin. Transl. Oncol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e250349","DOI":"10.1530\/EC-25-0349","article-title":"SLPI as a dedifferentiation biomarker in BRAFV600E-mutant papillary thyroid cancer","volume":"14","author":"Luo","year":"2025","journal-title":"Endocr. Connect."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/carcin\/bgm212","article-title":"The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and survival factor for ovarian cancer cells","volume":"29","author":"Simpkins","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1349-7006.2009.01076.x","article-title":"Overexpression of protease inhibitor-dead secretory leukocyte protease inhibitor causes more aggressive ovarian cancer in vitro and in vivo","volume":"100","author":"Devoogdt","year":"2009","journal-title":"Cancer Sci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12935-015-0182-4","article-title":"SLPI knockdown induced pancreatic ductal adenocarcinoma cells proliferation and invasion","volume":"15","author":"Zhang","year":"2015","journal-title":"Cancer Cell Int."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Yang, Y., Rhodus, N.L., Ondrey, F.G., Wuertz, B.R., Chen, X., Zhu, Y., and Griffin, T.J. (2014). Quantitative proteomic analysis of oral brush biopsies identifies secretory leukocyte protease inhibitor as a promising, mechanism-based oral cancer biomarker. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095389"},{"key":"ref_126","first-page":"1793","article-title":"Secretory leukocyte peptidase inhibitor expression and apoptosis effect in oral leukoplakia and oral squamous cell carcinoma","volume":"39","author":"Wang","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"140","DOI":"10.7150\/ijbs.65676","article-title":"SLPI suppresses hepatocellular carcinoma progression via endoplasmic reticulum stress induced apoptosis","volume":"18","author":"Sun","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2016.05.028","article-title":"Human uterus myoma and gene expression profiling: A novel in vitro model for studying secretory leukocyte protease inhibitor-mediated tumor invasion","volume":"379","author":"Mikami","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2334\/josnusd.16-0534","article-title":"Comparison of gene expression profiles of gingival carcinoma Ca9-22 cells and colorectal adenocarcinoma HT-29 cells to identify potentially important mediators of SLPI-induced cell migration","volume":"59","author":"Takamura","year":"2017","journal-title":"J. Oral Sci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"7748","DOI":"10.1158\/0008-5472.CAN-04-1827","article-title":"From mice to humans: Identification of commonly deregulated genes in mammary cancer via comparative SAGE studies","volume":"64","author":"Hu","year":"2004","journal-title":"Cancer Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1158\/0008-5472.CAN-05-0108","article-title":"Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease","volume":"65","author":"Kluger","year":"2005","journal-title":"Cancer Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/ijc.23660","article-title":"Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues","volume":"123","author":"Cimino","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00262-011-1018-2","article-title":"Immunotherapy with SLPI over-expressing mammary tumor cells decreases tumor growth","volume":"60","author":"Amiano","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jcp.24153","article-title":"Anti-tumor effect of SLPI on mammary but not colon tumor growth","volume":"228","author":"Amiano","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.18632\/aging.101372","article-title":"SLPI: A new target for stopping metastasis","volume":"10","author":"Munn","year":"2018","journal-title":"Aging"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1002\/1873-3468.70162","article-title":"From lactation to malignancy: A comparison between healthy and cancerous breast gland at single-cell resolution reveals new issues for tumorigenesis","volume":"599","author":"Ancona","year":"2025","journal-title":"FEBS Lett."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1832761","DOI":"10.1080\/2162402X.2020.1832761","article-title":"Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis","volume":"9","author":"Nugteren","year":"2020","journal-title":"Oncoimmunology"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"12174","DOI":"10.1038\/s41598-022-16427-5","article-title":"High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence","volume":"12","author":"Nugteren","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/pros.20792","article-title":"Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle","volume":"68","author":"Thompson","year":"2008","journal-title":"Prostate"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1038\/onc.2016.13","article-title":"Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer","volume":"35","author":"Zheng","year":"2016","journal-title":"Oncogene"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1002\/cam4.5134","article-title":"Up-regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy","volume":"12","author":"Miyazaki","year":"2023","journal-title":"Cancer Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/37.4.2926127","article-title":"Tissue distribution of antileukoprotease and lysozyme in humans","volume":"37","author":"Franken","year":"1989","journal-title":"J. Histochem. Cytochem."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1073\/pnas.0304146101","article-title":"Gene expression profiling identifies clinically relevant subtypes of prostate cancer","volume":"101","author":"Lapointe","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Liao, Y., Wu, M., Jia, Y., Mou, R., and Li, X. (2022). EpCAM as a Novel Biomarker for Survivals in Prostate Cancer Patients. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.843604"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1038\/s41598-023-28475-6","article-title":"Correlation analysis between immune-related genes and cell infiltration revealed prostate cancer immunotherapy biomarkers linked to T cells gamma delta","volume":"13","author":"Niu","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Zhai, X., Chen, X., Wan, Z., Ge, M., Ding, Y., Gu, J., Hua, J., Guo, D., Tan, M., and Xu, D. (2023). Identification of the novel therapeutic targets and biomarkers associated of prostate cancer with cancer-associated fibroblasts (CAFs). Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1136835"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e15013","DOI":"10.7717\/peerj.15013","article-title":"Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer","volume":"11","author":"Zhang","year":"2023","journal-title":"PeerJ"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13045-020-00943-w","article-title":"ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21","volume":"13","author":"Cosi","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccr.2005.10.001","article-title":"Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression","volume":"8","author":"Varambally","year":"2005","journal-title":"Cancer Cell"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Chandran, U.R., Ma, C., Dhir, R., Bisceglia, M., Lyons-Weiler, M., Liang, W., Michalopoulos, G., Becich, M., and Monzon, F.A. (2007). Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer, 7.","DOI":"10.1186\/1471-2407-7-64"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1086\/302994","article-title":"Evidence for a prostate cancer-susceptibility locus on chromosome 20","volume":"67","author":"Berry","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/318797","article-title":"Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer","volume":"68","author":"Bock","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s004390100513","article-title":"Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families","volume":"108","author":"Zheng","year":"2001","journal-title":"Hum. Genet."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.canlet.2003.09.016","article-title":"TNF-alpha-mediated apoptosis in normal human prostate epithelial cells and tumor cell lines","volume":"203","author":"Chopra","year":"2004","journal-title":"Cancer Lett."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/me.2010-0312","article-title":"TNF is necessary for castration-induced prostate regression, whereas TRAIL and FasL are dispensable","volume":"25","author":"Davis","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0092-8674(00)80127-0","article-title":"TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice","volume":"86","author":"Cui","year":"1996","journal-title":"Cell"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1172\/JCI200318899","article-title":"TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression","volume":"112","author":"Tang","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","article-title":"TGF\u03b2 biology in cancer progression and immunotherapy","volume":"18","author":"Derynck","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_160","first-page":"318","article-title":"Alterations in TGF\u03b2 signaling during prostate cancer progression","volume":"9","author":"Johnson","year":"2021","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"8118","DOI":"10.1158\/0008-5472.CAN-04-4562","article-title":"The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer","volume":"65","author":"Kim","year":"2005","journal-title":"Cancer Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"10765","DOI":"10.1093\/nar\/gks888","article-title":"Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions","volume":"40","author":"Decker","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"L269","DOI":"10.1152\/ajplung.00290.2013","article-title":"Regulation and activity of secretory leukoprotease inhibitor (SLPI) is altered in smokers","volume":"306","author":"Meyer","year":"2014","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cell.2018.06.039","article-title":"Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer","volume":"174","author":"Quigley","year":"2018","journal-title":"Cell"},{"key":"ref_165","unstructured":"(2020). Observational Prospective Study. SLPI: A Novel Biomarker of Prostate Cancer. Exploratory Study of SLPI Expression in Human Prostate Cancer Patients (Standard No. NCT04854343)."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/3\/487\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T05:19:51Z","timestamp":1770095991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/3\/487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":165,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["cancers18030487"],"URL":"https:\/\/doi.org\/10.3390\/cancers18030487","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]}}}